This announcement is a separate document:
艾迪药业董事会关于公司本次重大资产重组符合《上市公司重大资产重组管理办法》第十一条规定的说明
The board of directors of Jiangsu Aidea Pharmaceutical has provided an explanation regarding this major asset restructuring that complies with Article 11 of the Management Measures for Major Asset Restructuring of Listed Companies.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.